Less Frequent Sequence Mismatches in Variants of Concern (VOCs) of SARS-CoV-2 in the Real-Time RT-PCR Assays Developed by the National Institute of Infectious Diseases, Japan
Various variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The variants GRY/VOC202012/01 (B1.1.7), GH/N501Y.V2 (B1.351), and GR/N501Y.V3 (P1) are characterized by N to Y amino acid substitution at position...
Saved in:
Published in | Japanese Journal of Infectious Diseases Vol. 75; no. 1; pp. 96 - 101 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Japan
National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
31.01.2022
Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Various variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The variants GRY/VOC202012/01 (B1.1.7), GH/N501Y.V2 (B1.351), and GR/N501Y.V3 (P1) are characterized by N to Y amino acid substitution at position 501 in the S protein. The variant containing L to R substitution at position 452 in the S protein G/L452R.V3 (B1.617) was endemic to India. The heightened concern regarding these variants is related to their increased viral infectivity. Information about nucleotide mismatch(es) on the primer/probe sequence is important for maintaining good performance of real-time PCR assays. In this study, real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan (NIID-N2 and NIID-S2 assays), were reviewed to analyze nucleotide mismatches of variants in primer/probe sequences. The frequency of mismatched sequences in three variants (GRY/VOC202012/01, GH/N501Y.V2, and GR/N501Y.V3) was lower than that in all SARS-CoV-2 sequences. The mismatch, that G to C substitution at nucleotide 8 in reverse primer of S2 set, elevated to about 16.3% in G/L452R.V3, however the substitution did not affect the analytical sensitivity of assay. Therefore, the study indicates that the NIID-N2 and NIID-S2 sets detect VOCs of SARS-CoV-2 with reliable efficiency. |
---|---|
AbstractList | Various variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The variants GRY/VOC202012/01 (B1.1.7), GH/N501Y.V2 (B1.351), and GR/N501Y.V3 (P1) are characterized by N to Y amino acid substitution at position 501 in the S protein. The variant containing L to R substitution at position 452 in the S protein G/L452R.V3 (B1.617) was endemic to India. The heightened concern regarding these variants is related to their increased viral infectivity. Information about nucleotide mismatch(es) on the primer/probe sequence is important for maintaining good performance of real-time PCR assays. In this study, real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan (NIID-N2 and NIID-S2 assays), were reviewed to analyze nucleotide mismatches of variants in primer/probe sequences. The frequency of mismatched sequences in three variants (GRY/VOC202012/01, GH/N501Y.V2, and GR/N501Y.V3) was lower than that in all SARS-CoV-2 sequences. The mismatch, that G to C substitution at nucleotide 8 in reverse primer of S2 set, elevated to about 16.3% in G/L452R.V3, however the substitution did not affect the analytical sensitivity of assay. Therefore, the study indicates that the NIID-N2 and NIID-S2 sets detect VOCs of SARS-CoV-2 with reliable efficiency. Various variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The variants GRY/VOC202012/01 (B1.1.7), GH/N501Y.V2 (B1.351), and GR/N501Y.V3 (P1) are characterized by N to Y amino acid substitution at position 501 in the S protein. The variant containing L to R substitution at position 452 in the S protein G/L452R.V3 (B1.617) was endemic to India. The heightened concern regarding these variants is related to their increased viral infectivity. Information about nucleotide mismatch(es) on the primer/probe sequence is important for maintaining good performance of real-time PCR assays. In this study, real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan (NIID-N2 and NIID-S2 assays), were reviewed to analyze nucleotide mismatches of variants in primer/probe sequences. The frequency of mismatched sequences in three variants (GRY/VOC202012/01, GH/N501Y.V2, and GR/N501Y.V3) was lower than that in all SARS-CoV-2 sequences. The mismatch, that G to C substitution at nucleotide 8 in reverse primer of S2 set, elevated to about 16.3% in G/L452R.V3, however the substitution did not affect the analytical sensitivity of assay. Therefore, the study indicates that the NIID-N2 and NIID-S2 sets detect VOCs of SARS-CoV-2 with reliable efficiency.Various variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The variants GRY/VOC202012/01 (B1.1.7), GH/N501Y.V2 (B1.351), and GR/N501Y.V3 (P1) are characterized by N to Y amino acid substitution at position 501 in the S protein. The variant containing L to R substitution at position 452 in the S protein G/L452R.V3 (B1.617) was endemic to India. The heightened concern regarding these variants is related to their increased viral infectivity. Information about nucleotide mismatch(es) on the primer/probe sequence is important for maintaining good performance of real-time PCR assays. In this study, real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan (NIID-N2 and NIID-S2 assays), were reviewed to analyze nucleotide mismatches of variants in primer/probe sequences. The frequency of mismatched sequences in three variants (GRY/VOC202012/01, GH/N501Y.V2, and GR/N501Y.V3) was lower than that in all SARS-CoV-2 sequences. The mismatch, that G to C substitution at nucleotide 8 in reverse primer of S2 set, elevated to about 16.3% in G/L452R.V3, however the substitution did not affect the analytical sensitivity of assay. Therefore, the study indicates that the NIID-N2 and NIID-S2 sets detect VOCs of SARS-CoV-2 with reliable efficiency. |
ArticleNumber | JJID.2021.213 |
Author | Matsuyama, Shutoku Takeda, Makoto Shirato, Kazuya |
Author_xml | – sequence: 1 fullname: Shirato, Kazuya organization: Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, Japan – sequence: 2 fullname: Matsuyama, Shutoku organization: Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, Japan – sequence: 3 fullname: Takeda, Makoto organization: Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34193667$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc-O0zAQxiO0iP0DT4CELHFZJFLs2HGSY5VloVVhUVt6tRxnQl0Sp2u7SH0pnhGnLZXYCxePNfP7xp75rqML0xuIotcEj7I8px_2_U8wo-l0cjdKcEJGCaHPoiuS5yxOcsovwp0yFnOK2WV07dwG4yRNCX4RXVJGCsp5dhX9noFz6N7C4w6MR4tDVIC-aNdJr9bgkDZoJa2WxjvUN6jsQ90adLt6KN27IbMYzxdx2a_iZGD9GtAcZBsvdRduy_hbOUdj5-TeoTv4BW2_hRpV-wP4VXrdG9miiXFe-52HoeHENKBCYRcU2oF04N6jqdxK8zJ63sjWwatTvIm-339clp_j2cOnSTmexYpz7OMGy4QnVcWzlEtVQUYzzCTUYUWQprzBTU0IhwoUCwnJMYSF1TUrKsKLBoDeRLfHvlvbh404LzrtFLStNBC-JZKUZSnNioIF9O0TdNPvbJgpUDxhPGdZQQP15kTtqg5qsbW6k3Yv_joRAHoElO2ds9CcEYLF4Lc4-C0Gv8XgtwjDBFXxRKW0P-zUW6nb_2gnR-3GefkDzu9J67Vq4aTJUkGG4x_tmVFraQUY-ge-dcwj |
CitedBy_id | crossref_primary_10_1016_j_jviromet_2023_114812 crossref_primary_10_7883_yoken_JJID_2022_556 crossref_primary_10_3390_pathogens11030302 crossref_primary_10_1038_s41467_022_33911_8 crossref_primary_10_1128_jvi_01853_24 crossref_primary_10_1128_spectrum_00986_24 |
Cites_doi | 10.1093/cid/ciab411 10.1128/JCM.00921-21 10.1038/s41586-020-2008-3 10.2807/1560-7917.ES.2020.26.1.2002106 10.1126/science.abg3055 10.1038/s41586-021-03324-6 10.1038/s41586-021-03402-9 10.7883/yoken.JJID.2020.1079 10.7883/yoken.JJID.2020.061 10.1093/bib/bbx108 10.1101/2021.01.26.21250543 |
ContentType | Journal Article |
Copyright | 2022 Authors Copyright Japan Science and Technology Agency 2022 |
Copyright_xml | – notice: 2022 Authors – notice: Copyright Japan Science and Technology Agency 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
DOI | 10.7883/yoken.JJID.2021.213 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1884-2836 |
EndPage | 101 |
ExternalDocumentID | 34193667 10_7883_yoken_JJID_2021_213 article_yoken_75_1_75_JJID_2021_213_article_char_en |
Genre | Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- .55 29J 2WC 53G 5GY ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL DIK DU5 E3Z EBS EJD F5P FRP GX1 JSF JSH KQ8 OK1 RJT RNS RZJ TR2 W2D X7M XSB AAYXX CITATION OVT CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
ID | FETCH-LOGICAL-c660t-f0a262bb6756acbe73704aed213e556f0fd116ebec43e5a60e836dd49b169fee3 |
ISSN | 1344-6304 1884-2836 |
IngestDate | Thu Jul 10 18:48:37 EDT 2025 Mon Jun 30 11:56:39 EDT 2025 Thu Jan 02 22:55:51 EST 2025 Thu Apr 24 22:53:09 EDT 2025 Tue Jul 01 03:55:16 EDT 2025 Thu Aug 17 20:30:00 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | real-time RT-PCR variant of concern (VOC) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus diseases 2019 (COVID-19) |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c660t-f0a262bb6756acbe73704aed213e556f0fd116ebec43e5a60e836dd49b169fee3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/yoken/75/1/75_JJID.2021.213/_article/-char/en |
PMID | 34193667 |
PQID | 2624684793 |
PQPubID | 2048383 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2547537994 proquest_journals_2624684793 pubmed_primary_34193667 crossref_primary_10_7883_yoken_JJID_2021_213 crossref_citationtrail_10_7883_yoken_JJID_2021_213 jstage_primary_article_yoken_75_1_75_JJID_2021_213_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022/01/31 |
PublicationDateYYYYMMDD | 2022-01-31 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022/01/31 day: 31 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Japanese Journal of Infectious Diseases |
PublicationTitleAlternate | Jpn J Infect Dis |
PublicationYear | 2022 |
Publisher | National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee Japan Science and Technology Agency |
Publisher_xml | – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee – name: Japan Science and Technology Agency |
References | 12. Tchesnokova V, Kulakesara H, Larson L, et al. Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants. J Clin Microbiol. 2021;59:e0092121. 14. Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform. 2019;20:1160-1166. 4. Shirato K, Tomita Y, Katoh H, et al. Performance evaluation of real-time RT-PCR assays for detection of severe acute respiratory syndrome coronavirus-2 developed by the National Institute of Infectious Diseases, Japan. Jpn J Infect Dis. 2021;74:465-472. 3. Shirato K, Nao N, Katano H, et al. Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan. Jpn J Infect Dis. 2020;73:304-307. 11. Latif AA, Mullen JL, Alkuzweny M, et al. India Mutation Report. Available at <https://outbreak.info/location-reports?loc=IND>. Accessed May 26, 2021. 5. Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372:eabg3055. 6. Tegally H, Wilkinson E, Giovanetti M, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592:438-443. 1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265-269. 8. Leung K, Shum MH, Leung GM, et al. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Euro Surveill. 2021;26:2002106. 10. Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616-622. 13. Yadav PD, Sapkal GN, Abraham P, et al. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clin Infect Dis. 2021; ciab411. doi: 10.1093/cid/ciab411. 2. World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. Available at <https://covid19.who.int/>. Accessed October 21, 2020. 9. Jangra S, Ye C, Rathnasinghe R, et al. The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. medRxiv. 2021. doi: https://doi.org/10.1101/2021.01.26.21250543. Preprint. 7. National Institute of Infectious Diseases, Japan. Brief report: New Variant Strain of SARS-CoV-2 Identified in Travelers from Brazil. Available at <https://www.niid.go.jp/niid/images/epi/corona/covid19-33-en-210112.pdf>. Accessed March 9, 2021. 11 12 13 14 1 2 3 4 5 6 7 8 9 10 |
References_xml | – reference: 1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265-269. – reference: 3. Shirato K, Nao N, Katano H, et al. Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan. Jpn J Infect Dis. 2020;73:304-307. – reference: 6. Tegally H, Wilkinson E, Giovanetti M, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592:438-443. – reference: 7. National Institute of Infectious Diseases, Japan. Brief report: New Variant Strain of SARS-CoV-2 Identified in Travelers from Brazil. Available at <https://www.niid.go.jp/niid/images/epi/corona/covid19-33-en-210112.pdf>. Accessed March 9, 2021. – reference: 8. Leung K, Shum MH, Leung GM, et al. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Euro Surveill. 2021;26:2002106. – reference: 10. Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616-622. – reference: 12. Tchesnokova V, Kulakesara H, Larson L, et al. Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants. J Clin Microbiol. 2021;59:e0092121. – reference: 14. Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform. 2019;20:1160-1166. – reference: 9. Jangra S, Ye C, Rathnasinghe R, et al. The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. medRxiv. 2021. doi: https://doi.org/10.1101/2021.01.26.21250543. Preprint. – reference: 2. World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. Available at <https://covid19.who.int/>. Accessed October 21, 2020. – reference: 5. Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372:eabg3055. – reference: 11. Latif AA, Mullen JL, Alkuzweny M, et al. India Mutation Report. Available at <https://outbreak.info/location-reports?loc=IND>. Accessed May 26, 2021. – reference: 4. Shirato K, Tomita Y, Katoh H, et al. Performance evaluation of real-time RT-PCR assays for detection of severe acute respiratory syndrome coronavirus-2 developed by the National Institute of Infectious Diseases, Japan. Jpn J Infect Dis. 2021;74:465-472. – reference: 13. Yadav PD, Sapkal GN, Abraham P, et al. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clin Infect Dis. 2021; ciab411. doi: 10.1093/cid/ciab411. – ident: 2 – ident: 13 doi: 10.1093/cid/ciab411 – ident: 12 doi: 10.1128/JCM.00921-21 – ident: 1 doi: 10.1038/s41586-020-2008-3 – ident: 8 doi: 10.2807/1560-7917.ES.2020.26.1.2002106 – ident: 11 – ident: 5 doi: 10.1126/science.abg3055 – ident: 10 doi: 10.1038/s41586-021-03324-6 – ident: 6 doi: 10.1038/s41586-021-03402-9 – ident: 4 doi: 10.7883/yoken.JJID.2020.1079 – ident: 7 – ident: 3 doi: 10.7883/yoken.JJID.2020.061 – ident: 14 doi: 10.1093/bib/bbx108 – ident: 9 doi: 10.1101/2021.01.26.21250543 |
SSID | ssj0025510 |
Score | 2.3118782 |
Snippet | Various variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 96 |
SubjectTerms | Amino acid substitution Amino acids Assaying Communicable Diseases coronavirus diseases 2019 (COVID-19) Coronaviruses COVID-19 Humans Infectious diseases Infectivity Japan Mutation Nucleotides Polymerase chain reaction Protein G Proteins Real time Real-Time Polymerase Chain Reaction real-time RT-PCR Respiratory diseases Reverse Transcriptase Polymerase Chain Reaction SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Substitutes variant of concern (VOC) Viral diseases |
Title | Less Frequent Sequence Mismatches in Variants of Concern (VOCs) of SARS-CoV-2 in the Real-Time RT-PCR Assays Developed by the National Institute of Infectious Diseases, Japan |
URI | https://www.jstage.jst.go.jp/article/yoken/75/1/75_JJID.2021.213/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/34193667 https://www.proquest.com/docview/2624684793 https://www.proquest.com/docview/2547537994 |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of Infectious Diseases, 2022/01/31, Vol.75(1), pp.96-101 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELeqgRAviP8UBjISD6AtpUkcJ3kchWmrKKC2q_oWOYnDRiFBTfrQfSg-Fp-Duzh2m2lMjJeodZxTkvv5fOf87kzIqyQDk5cFiSW9MLSYsGHMSS4sEfDEDTIvDusSG6NP_OiEDefevNP5vcVaWlVxLzm_NK_kf7QKbaBXzJK9hmaNUGiA36BfOIKG4fhPOv6IZupwWbOhKxj2ihW9NzorwQ_FnbBwNWMG0bAmuwwwSXGJ-g5mnwclLglg0srBeGINipnlaNbjGNxHC7ND9sZT68tgjFoU61JTjBqvFemRei2xRTo4bhheqxKre-IHIIUWmJjzljeMDbKU7foV5trm45Hx-ienNSlAkUDOV2szo4xEVcLfH7UjPDldVcVitVmSWMhUqLSkRVEV28scDvJF9PygLLPLmMVdtVdxT6q2IGAW-Ed825yrjVhasFW2OeRbs7ytllAuTiB-EGAhi3WxkHlvODx-34N7sXuOypdtl-u-MI0aciOEVSgmqoVEKCRCIZGDmyvfcCCcqZPS54aKBFGdqpqhH1FVx0Ihby-5k5YHdfMbBBFf5d_jo9pPmt4ld5oAhx4otN4jHZnfJ7dGDYXjAfmFoKUatFSDlm5AS89yqkFLi4w2oKWvEbJvsGUDWOwLOKQGsFQBlirAUgNYGq_rjhqw1AAWBW4ASzVg92mNzofk5PDDdHBkNZuGWAnn_crK-sLhThxDIMxFEkvf9ftMyBRenPQ8nvWz1LY5mi4GDYL3JeAnTVkY2zzMpHQfkZ28yOUTQmNPpAw3zJMZYzzloR1KAXJ9OxNe4vld4mhFRElTUR83dvkeXQGBLtk3F_1UBWWu7v5Oadh0bqxN09n3IhsPrYtMH8zcBEPZJbsaHVEzoMsI3hLjAS6sd8lLcxomF_xiCIMfXnnkeMz3XD8MWZc8Vqgy94GFIF3O_afXe6Bn5PZmeO-SnWq5ks_Br6_iF_Wg-APA1_tz |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Less+Frequent+Sequence+Mismatches+in+Variants+of+Concern+%28VOCs%29+of+SARS-CoV-2+in+the+Real-Time+RT-PCR+Assays+Developed+by+the+National+Institute+of+Infectious+Diseases%2C+Japan&rft.jtitle=Japanese+journal+of+infectious+diseases&rft.au=Shirato%2C+Kazuya&rft.au=Matsuyama%2C+Shutoku&rft.au=Takeda%2C+Makoto&rft.date=2022-01-31&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=75&rft.issue=1&rft.spage=96&rft.epage=101&rft_id=info:doi/10.7883%2Fyoken.JJID.2021.213&rft.externalDBID=n%2Fa&rft.externalDocID=10_7883_yoken_JJID_2021_213 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon |